Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing an important role for Manufacturing Engineering support within the Drug Substance (DS) function, reporting to the Principal Engineer, and working closely with process chemists, engineers, and business operations, the successful candidate will be responsible for supporting late-stage and commercial manufacturing of Revolution Medicines’ compounds across a variety of CDMOs, including RSM synthesis. Responsibilities may also include back-up support for early and late-stage production of Revolution Medicines’ compounds.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level